RENZIGA

Welcome to the Brand page for “RENZIGA”, which is offered here for Pharmaceutical preparations for the treatment of various diseases, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of rnai therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;scientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “RENZIGA” is believed to be currently owned by “Dicerna Pharmaceuticals, Inc.”